Dermal Fillers should be prescription only recommends Sir Bruce Keogh Cosmetic Intervention Review

Posted on the 24 April 2013 at 08:54

The long awaited report following the review into the Regulation of Cosmetic Interventions in England, led by NHS Medical Director, Sir Bruce Keogh and a panel of advisors has been published today calling for a complete reclassification of dermal filler products amongst other recommendations for the private cosmetic sector.

The Keogh committee also want to ensure that all practitioners are properly qualified for all the procedures that they offer, from cosmetic surgeons offering breast augmentations to those offering cosmetic injectable treatments. All of which would be overseen by an ombudsman to aid those who have received poor treatment. Thus far the report and its contents have been welcomed by key organisations within the aesthetic industry.

Commissioned by the Government following the PIP breast implant scandal, the review has looked at the products used for surgical and non-surgical procedures, the people who administer them, the way they are advertised and the advice and support patients and consumers are given. The report sets out how it would like to see the aesthetic and cosmetic sector better regulated, practitioners better trained and the public having proper redress should things go wrong.

On first dissecting the industry, Sir Keogh admitted to being surprised that non-surgical interventions, which can have major and irreversible impacts on health if something goes wrong, are almost entirely unregulated. He summed it up by saying; “In fact, a person having a non-surgical cosmetic intervention has no more protection and redress than someone buying a ballpoint pen or a toothbrush.

Of particular concern to the committee was the arena of dermal fillers where they noted that anyone can set themselves up as a practitioner, with no requirement for knowledge, training or previous experience and, in the absence of accredited training courses, anyone can set up a training course purporting to offer a (self-accredited) qualification. The casual use of products by unqualified individuals and reports of people buying injectable products over the Internet and self-administering alarmed the Keogh panel. Add to that the lack of sufficient checks in regard to the quality of the filler products themselves, currently poorly regulated under medical device regulations, which was likened to those imposed on a bottle of floor cleaner, meaning that the Review committee believes that dermal fillers are a crisis waiting to happen.

They also noted that data on rates of reported adverse reactions caused by dermal fillers and other non-surgical cosmetic interventions are poor because there are no formal reporting mechanisms in place for many of these products.

Sir Keogh raised the issue that previous attempts at self-regulation in the non-surgical side of the industry have failed, which he put down to them being largely voluntary codes which have meant that only the best in the industry commit themselves to better practice, whilst the unscrupulous and unsafe carry on as before.  The report states that despite efforts from IHAS, Treatments You Can Trust has attained limited support from the sector, with concerns that, as a trade body, IHAS is not the appropriate organisation to run an independent register. It also points out that from a consumer perspective awareness of the register is low. It concludes that the failure of the sector to self-regulate may also partly reflect public attitudes which assume that there is already legislation. An observation which we would all be hard pressed to disagree with.

For this reason, one of the key recommendations of the report is to make dermal fillers prescription only medical devices to tackle both concerns head on. The committee are determined that the production of dermal fillers should fall under the same controls as other implants as this will ensure that only those fillers that have passed vigorous appraisals of safety will be available, and only those with ‘appropriate skill’ will be able to administer them.

Commenting on the report, Consulting Room™ Advisor, Consultant Plastic Surgeon and BAAPS President Rajiv Grover said; “We are thoroughly relieved that the Review has come to the same conclusions as we have over the years, specifically the urgent need for dermal fillers to require a prescription for use. This measure will kill three birds with one stone: regulating which ones come onto the market, who can inject them and automatically banning their advertising.

The Review report notes that people undergoing non-surgical treatments should be able to be confident that their practitioner has the required skill and expertise to undertake the procedure successfully and safely.

They argue that the question is not ‘who should perform treatments’ but ‘what should adequate training and accreditation involve’? Noting that once the requirements for training are identified and understood, it should be possible to identify, for each professional group, which parts of the curriculum have been covered with prior training and which are consequently required to complete training. This will mean that different professional groups (e.g. medics like Doctors and Nurses versus non-medics like Beauty Therapists) will enter the training scheme at different points. Such a scheme could provide broad access, and may be able to provide professional training for those with no prior experience. The aim should be that, every practitioner, no matter what their starting point should attain the necessary skills and expertise to perform these varied procedures safely and to a high standard.

The training and accreditation process should ensure that practitioners are able to identify and manage complications of treatment and the curriculum and training requirements should be regularly reviewed to ensure that all practitioners are adequately trained in emerging procedures; this will involve regular retraining for those who wish to perform the latest treatments.

The committee believes that anyone prescribing fillers, or performing other potentially harmful non-surgical cosmetic procedures, should be accountable to a professional regulator.

The Review committee thus recommends that:

  • All non-surgical procedures must be performed under the responsibility of a clinical professional who has gained the accredited qualification to prescribe, administer and supervise aesthetic procedures.
  • Non-healthcare practitioners who have achieved the required accredited qualification may perform these procedures under the supervision of an appropriate qualified clinical professional.
  • The Government’s mandate for Health Education England (HEE) should include the development of appropriate accredited qualifications for providers of non-surgical interventions and it should determine accreditation requirements for the various professional groups. This work should be completed in 2013.
  • All practitioners must be registered centrally. The register should be independent of particular professional groups or commercial bodies, and should be funded through registration fees.
  • Entry to the register should be subject to:
    • achievement of accredited qualification
    • premises meeting certain requirements
    • adherence to a code of practice that covers handling complaints and redress,
    • insurance requirements, responsible advertising practice and consent practices
    • continued demonstration of competence through an annual appraisal.

Following on from this the Review committee found that the current regulation of non-surgical providers is insufficient to adequately protect public health and safety.

Therefore they recommend that:

  • Those training to be non-surgical practitioners should have a clear understanding of the requirement to operate from safe premises, and the responsibilities involved. The training curriculum should include topics such as infection control, treatment room safety and adverse incident reporting. The code of conduct for those on the register should include an obligation to abide by certain clearly defined minimum standards for premises.

Sally Taber, Director of the Independent Healthcare Advisory Services and responsible for managing www.TreatmentsYouCanTrust.org.uk welcomed the Keogh Review and said; "The successful implementation of the recommendations on non-surgical procedures to ensure patient safety relies on two things. First, to end bad practice, the new qualification for cosmetic injectables must be underpinned by medical knowledge to ensure these medical treatments are administered safely. Second, it is important that these recommendations are executed swiftly to stop patients falling through the net. IHAS will be happy to utilise its existing framework and established industry guidelines to work constructively with the Government to expedite the process."

In relation to the products themselves, the Review report states that dermal fillers that do not claim to have a medical purpose (i.e. they are purely for cosmetic use) are exempt from EU medical device regulations and CE marking requirements before being able to be sold, thus products falling outside the medical devices regulations are only covered by the general provisions of the EU General Product Safety Directive. This maintains only a very general responsibility on distributors to place on the market (or supply) products that are safe in normal or reasonably foreseeable use.  Furthermore, when a product such as a dermal filler is used as part of a ‘professional service’ it is currently exempt from the EU General Product Safety Directive. This means that in effect some dermal fillers used in cosmetic interventions in the UK are exempt from any product safety regulations! While this does not necessarily mean that the products are unsafe, it does mean that consumers and patients are reliant on manufacturers’ and providers’ own assessment of the safety of the product.

The Review report highlights that proposed revisions to the EU Medical Devices Directive are currently being discussed and may result in all dermal fillers and other implants for cosmetic use being classified as medical devices and therefore subject to the safety checks required for CE marking, but even if these changes are agreed, they are unlikely to be implemented before 2018, which Keogh believes leaves the public unprotected for too long. Manufacturers are currently not required to notify the MHRA that they are bringing medical devices or cosmetic implants to market in the UK and it is difficult therefore to get data on product use. According to the report, as a rough estimate, there are between 140 and 190 dermal filler products available in the UK (including CE marked and non-CE marked products), and there are no restrictions on who can purchase these products.

It therefore recommends that:

  • The scope of the EU Medical Devices Directive should be extended to cover all cosmetic implants, including all dermal fillers. UK legislation should be introduced to make fillers a prescription only medical devices.
  • The EU General Product Safety Directive (GPSD) should be revised so that products used as part of a professional service are no longer exempt from product safety legislation.
  • Manufacturers should inform the MHRA when bringing a new product to the UK market and the MHRA should publish a list of the cosmetic devices available in the UK.


The 67 page report of course goes into much more detail about the various aspects of the cosmetic intervention market within England and its findings and recommendations.  The Review Committee believes that the Government needs to establish a regulatory framework that encompasses the whole cosmetic sector, rather than the ‘piecemeal’ set up that it currently sees. This would employ a ‘clear, consistent and proportionate approach that is able to adapt to new developments’. The panel therefore hope that their recommendations, taken together, form a new legislative framework, demanded consistently by stakeholders and contributors to the evidence process that is proportionate to the potential risks of cosmetic interventions. The full report (Review of the Regulation of Cosmetic Interventions) highlights three key areas in which changes are needed within the whole industry:

1. high quality care with safe products, skilled practitioners and responsible providers;
2. an informed and empowered public to ensure people get accurate advice and that the vulnerable are protected;
3. and, accessible redress and resolution in case things go wrong.

The key recommendations are thus laid out as follows:

High Quality Care

  • The scope of the EU Medical Devices Directive should be extended to include all cosmetic implants including dermal fillers, UK legislation should be introduced to enact the changes sooner. Legislation should be introduced to classify fillers as a prescription-only medical device.
  • The Royal College of Surgeons (RCS) should establish an Interspecialty Committee on Cosmetic Surgery, made up of representatives of all the relevant specialty and professional associations. The purpose of this group is to set standards for cosmetic surgery practice and training, and make arrangements for formal certification of all surgeons regarded as competent to undertake cosmetic procedures, taking account of training and experience.
  • All those performing cosmetic interventions must be registered.
  • The Health Education England’s (HEE’s) mandate should include the development of appropriate accredited qualifications for providers of non-surgical interventions and it should determine accreditation requirements for the various professional groups. This work should be completed in 2013.
  • Surgical providers should provide both the person undergoing a procedure and their GP with proper records.
  • A breast implant registry should be established within the next 12 months and extended to other cosmetic devices as soon as possible, to provide better monitoring of patient outcomes and device safety.

An Informed and Empowered Public

  • The RCS Interspecialty Committee on Cosmetic Surgery should develop and describe a multi-stage consent process for operations. Consent must be taken by the surgeon performing the operation to ensure that the patient and practitioner have a shared understanding of the desired outcome and the limitations, implications and risks of the procedure.
  • Evidence-based standardised patient information should be developed by the RCS Interspecialty Committee on Cosmetic Surgery, with input from patient organisations.
  • For non-surgical procedures a record of consent must be held by the provider.
  • Existing advertising recommendations and restrictions should be updated and better enforced.
  • The use of financial inducements and time-limited deals to promote cosmetic interventions should be prohibited to avoid inappropriate influencing of vulnerable consumers.

Accessible Resolution and Redress

  • The remit of the Parliamentary and Health Service Ombudsman (PHSO) should be extended to cover the whole private healthcare sector. This will de facto include cosmetic procedures of all kinds.
  • All individuals performing cosmetic procedures must possess adequate professional indemnity cover that is commensurate with the type of operations being performed.
  • For surgeons working in this country, but who are insured abroad, indemnity insurance must be commensurate with similar UK policies.
  • The Review Committee supports the future development of insurance products such as risk pool arrangements, to cover product failure and certain complications of surgery.


Sir Bruce is keen to put the minds of practitioner’s at rest by clarifying; “these recommendations are not about increasing bureaucracy but about putting everyone’s safety and wellbeing first.

He went on to say; “We would like to see everyone who chooses to have any cosmetic procedure better protected. We would like to see people who carry out procedures trained to a high standard. We would like the public to feel confident they are going to be well looked after and, if things go wrong, that they will be supported. And ultimately, if someone needs to step in on the side of patients, we think there should be an ombudsman to do that. We very much hope that our report will lead to a safer environment for patients and this industry in the future.

All we have to see now is if the present Government will implement any of these recommendations or simply ignore them. With many of them being a mirror of some of the concerns raised in the 2005 reports by the then Healthcare Commission, the Expert Group and the Chief Medical Officer, it is a little disheartening for many to see that the same problems and inadequacies persist close to a decade later.

We will be analysing the Keogh Review is more detail in our next Member Magazine, but would welcome your thoughts and comments on this lengthy blog, please let us know using the form below.


Updated 24th April 2013 - 11:30am

BAPRAS statement in response to the Department of Health’s Review of Regulation on Cosmetic Interventions:

Tim Goodacre, BAPRAS Chair of Professional Standards and a member of the Review’s Working Group on Training and Education in Cosmetic Surgery, said:

...This is a strong series of recommendations and we are pleased that many of our priorities have been included.  We hope they achieve Parliamentary approval and support quickly so that the detailed implementation work can begin and patients can be sure of high quality care and controlled outcomes at all times.

Full response from BAPRAS to the Keogh recommendations.


Updated 24th April 2013 - 12:00pm

BABTAC response to Government recommendations regarding Cosmetic Interventions:

Carolyne Cross, Chair of BABTAC & CIBTAC says ;

"Whilst not all the changes are consistent with our own recommendations for cosmetic interventions, we are quietly confident that the outcome will work to benefit both the consumers and the industry practitioners. It is our belief that any changes should work to improve consumer safety and awareness, without creating a market monopoly and driving up prices. Our original submission to the Review and subsequent representations highlighted a number of the same recommendations and we are pleased that the Committee has taken a proactive and impartial approach. In terms of the impact on the beauty industry, we believe that there will be some significant changes in terms of regulations and qualifications, and as an organisation we have been driving for improved standards of training and regulation of our own industry providers. For therapists, it is likely that they will have to undertake additional training to become compliant, and whilst this has a cost implication for each salon, the outcome – better protected clients - will be worth the additional expenditure. We hope that these changes will serve to support and develop already reputable businesses, whilst undermining the status of ‘rogue traders’ who practice without due care and attention."

Full response from BABTAC to the Keogh recommendations.


Updated 24th April 2013 - 12:15pm

Allergan (maker of botulinum toxin brand Botoxâ and the Juvedermâ range of dermal fillers) response to Government recommendations regarding Cosmetic Interventions:

"Allergan is in favour of regulatory changes to classify all cosmetic implants including dermal fillers as medical devices and supports many of the other proposals such as calls to strengthen the existing European Medical Device Directive, plans to establish accredited training standards for health care professionals administering cosmetic implants, as well as steps to improve consultation and record keeping of patient treatments.

......

The report calls for a proposal to re-classify dermal fillers as prescription-only medical devices. This will require further thought to ensure the necessary legislation would bring about positive change in ensuring optimal patient outcomes. Specifically, any legislation change of this type will require significant time and could also mean that medical aesthetic nurses, who are generally already highly skilled and experienced, will need to re-train in order to obtain a prescribing licence."

Full response from Allergan to the Keogh recommendations.


Updated 24th April 2013 - 7:15pm

British College of Aesthetic Medicine (BCAM) response to Government recommendations regarding Cosmetic Interventions:

Dr Samantha Gammell, President BCAM said:

" BCAM is both pleased and relieved that the Review has put forward recommendations which are both sensible and proportionate in relation to cosmetic treatments. BCAM has long advocated the regulation of the use of dermal fillers in view of the potentially very serious complications which can arise from their use and we are delighted at the proposal that these products should become prescription only medicines. We also welcome the committee’s recommendations regarding requirements for verifiable training in the field of aesthetic medicine which is the central focus of the College.

In addition to the above the Review proposes that cosmetic treatments of all types should only be carried out by qualified clinical professionals who are prescribers or under the supervision of such professionals which would end the practice of administration of treatments by unqualified and untrained individuals performing treatments in unsuitable facilities.

We are thrilled that the Review has taken on board the views we expressed in our evidence to them late last year and that so many of our suggestions have been adopted by Professor Keogh and his team in the final report. It is vital for the sake of the profession that cosmetic surgery and aesthetic medicine is appropriately regulated and is performed only by those who are qualified, skilled and able to deal with the rare but potentially serious complications.

We look forward to working with the Department of Health, Health Education (England) and the other professional bodies in shaping the future direction of the speciality in the coming months and hope that the government will take Professor Keogh’s recommendations seriously and recognise the importance of regulation in this sector "


Updated 25th April 2013 - 10:30am

Royal College of Surgeons (RCS) response to Government recommendations regarding Cosmetic Interventions:

Professor Norman Williams, President of the RCS, said;

"We welcome this report and the recommendations to address the vacuum of regulation and standards that currently exists in cosmetic surgery. Over the past decade there have been numerous reports, a great deal of discussion but little action. The failure of PIP implants was a wake-up call that brought into sharp focus the desperate need for Government intervention to ensure commercial interests no longer take priority over patient safety. We call on Government to work with us to implement these recommendations without delay.

We support the committee’s recommendation that only doctors on a General Medical Council specialist register should perform cosmetic surgery and work within the scope of their specialty specific training. This is a start to addressing concerns about unqualified practitioners engaged in this work including some overseas surgeons operating in the UK. We welcome the opportunity to set clear standards for training and practice to ensure all surgeons are certified to the same standard irrespective of where they are trained.

We are also pleased that, as a priority, the review proposes a National Breast Implant Registry should be operational within 12 months. The College has long pressed for mandatory databases for all surgical implants to improve patient safety by keeping an audit trail of device failures and complications. We hope this registry will be rolled out across surgery so that all medical devices are covered."

Full response from RCS to the Keogh recommendations.


Updated 8th May 2013 - 10:00am

British Association of Cosmetic Nurses (BACN) response to Government recommendations regarding Cosmetic Interventions:

"If practitioners are to be licensed - who will license and how would it work? If there is to be accredited education - how will this be designed? what will the entry levels be? who will deliver and where will it be delivered? how will experienced practitioners demonstrate required standards? We strongly object to anyone other than nurses, doctors and dentists qualifying to undertake these procedures.

If Premises are to be licensed - who will undertake this? what lessons have we learned? We support initiation of the HEE, PHSO, CQC and MHRA in engagement and consultation with clinical experts in pushing forward the recommendations towards credible and workable legislation. The group of experts in this case MUST include clinicians with direct and significant experience in the practices examined. Nurses experienced in aesthetics must be included and the BACN fully commit to engaging in this necessary process.

The BACN supports the development of a mandatory national register of non-surgical licensed clinicians with practitioners demonstrating competency in the relevant non surgical speciality, subject to audit, assessment, appraisals and revalidation.

The Voluntary Register TYCT failed on a number of levels. TYCT did not reflect the challenges required of voluntary regulation in this area. They did not address the fundamentals of regulating individual providers. They were governed by a number of large organisations, driven by commercial imperatives who themselves demonstrated unacceptable standards which have been highlighted for change in the report. The practices of these TYCT Quality Marked companies were responsible for the initiation and basis of the report. The notion that "only the best commit to TYCT" does not stand up to examination. TYCT having failed to gain trust and credibility, despite its best efforts, should not have a place in the future regulatory landscape. We would advocate a new, robust, specifically tailored standards agency which is non-commercial, non-partisan and which draws on all current professional standards and evidence of good practice.

We agree strongly with the views expressed by the RCS that only trained clinicians should undertake these medical procedures and to advocate otherwise compromises public safety, which is the main issue that this report is designed to address.

The report appears to suggest that those who are not medical may become qualified to practice under supervision. With patient safety foremost, there is absolutely no imperative for this to be the case, and "under supervision " is open to interpretation.. In the NHS, Healthcare Assistants at the bedside rather than qualified nurses has proved this point.

Nurses and doctors are licensed and regulated by and accountable to their statutory bodies, The NMC and GMC. The BACN questions their level of engagement in the review and a lack of discussion on the responsibility they have to the registered nurses and doctors who opt to work in this specialty. The government committee believes that anyone performing potentially harmful non-surgical cosmetic treatments should be accountable to a professional regulator, such as NMC, GMC and GDC. We question why unregulated therapists are included in any plans for higher standards.

We agree that the scope of EU Medical Devices Directive should be extended to include dermal fillers. These devices should only be supplied to and administered by nurses, doctors and dentists who are educated, licensed, regulated and accountable. Prescription only medicines may be administered by ANYONE once prescribed.

We are engaging with other stakeholders - BCAM, BAD and manufacturers - to come together at the earliest opportunity to influence the future landscape. We will be lobbying the media and government."

Add Comment

To leave a comment you need to be logged in as a Cosmetic Community Member or a Clinic.

Please Click Here to login / register with the Cosmetic Community.

If you are a Clinic Click Here to login to the partners area of Consulting Room.

Blog Comment(s) [11]

the only formal qualification i am aware of at the moment is the diploma/MSc in Non Surgical Facial Aesthetics at UCLAN

Fab Equizi

Merz Aesthetics, the manufacturers of Bocouture® Botulinum toxin type A and dermal filler brands Radiesse® and Belotero® respond to Sir Brice Keogh’s review regarding cosmetic treatments:

"Merz Aesthetics warmly welcomes the move toward increased patient safety and care and believes that patients deserve a high level of quality and safety from our products and the medical aesthetic industry as a whole. As a pharmaceutical company with over a century’s heritage Merz has always followed the most stringent approach with our full portfolio, regardless of whether they are a medical device or a prescription medicine. All Merz Aesthetics products are both CE marked and approved by the United States’ FDA (arguably the world’s most stringent regulator). The Merz Aesthetics Field Clinical Specialists are a significant resource dedicated solely to supporting practitioner expertise in the administration of Merz products which we will only allow registered physicians, nurses or dentists to access. Merz ePharmacy also provides for routine checking of the corresponding GMC, NMC and GDC numbers of customer that wish to purchase from us through our GPhC approved pharmacy service. Through our educational programs we have advocated that practitioners should ensure they have adequate insurance cover and also ensure they follow comprehensive informed consent procedures for patients. Merz are fully behind the move to reinforce the general public’s perception of the UK medical aesthetics industry as professional, caring and above all, safe."

Merz Aesthetics

Statement from MYA on the Regulation of Cosmetic Interventions

MYA Cosmetic Surgery is delighted with Sir Bruce Keogh and his committees Review of the Regulation of Cosmetic Interventions. MYA already adopts most of the 46 recommendations and the company look forward to working with any working party to make the remainder a reality.

"I have been in the cosmetic surgery business since the 1970?s and this is a turning point. All credible parties need to work together to keep up momentum to turn the recommendations into reality. MYA will make available resources to assist with this. I would like the UK to be seen as the safest provider of cosmetic surgery in the world and for MYA to set the standard in terms of the quality of surgical results, transparency of information and the quality of patient care and experience. We are the only major cosmetic surgery provider in the UK who has an online forum (www.mya.co.uk/mya-space) and links each of our clinics website pages to the Care Quality Commission website. This allows prospective patients access directly to the CQC assessment report. Our next phase is to publish data around the number and type of procedures that we carry out and any revision and complication rates involved as we are confident that the quality of our offering is exceptional. We will not wait for the government to implement this action; we will take a direct lead as data transparency is key to driving up standards in the industry."

John Ryan (MYA Chairman)

Response to Keogh from Courthouse Clinics and Dr. Patrick Bowler.

"...for far too long there have been too many unregulated procedures that reflect badly on the whole industry. Dermal fillers and laser treatments for wrinkles and hair reduction make up 90% of the sector, worth over 2 billion pounds in the U.K., yet these procedures have been subject to little or no regulation, despite the fact that they can have major, permanent effects on people's health and wellbeing. This gives even the most outstanding clinics a bad name.

For a nationwide company like mine, Courthouse Clinics, the recommendations have positive ramifications. There are often higher levels of scrutiny within the cosmetic surgery arena, due to enhanced marketing, competition and public interest. Particularly after the `PIP Storm` of last year, we needed, as an industry in the spotlight, a review board.

It's been a long time coming to look at how legitimate practitioners and patients alike could protect themselves from bogus `technicians` practicing unlicensed out of beauty salons, compromising the integrity of establishments like my practice. Courthouse Clinics, like many other reputable establishments, are part of IHAS - the Independent Healthcare Advisory Services - and have contributed much of the safety data that has led to the conclusions reached."

Full response available here

Dr. Patrick Bowler

I was very happy to hear about this. For too long corporations in the medical field were putting profits ahead of patients and this latest PIP fiasco was the last straw. Something has to be done about this and fast.

Pavel S

Great overview thanks, glad to see some sensible changes being brought in ;)

Dr Ricky Adams

Excellent recommendations, although as a one woman one room set up I'm concerned I might not make the grade! Lots of hoops to jump through-quite rightly but its probably harder for a small practice with limited resources, will wait and see what the outcome on the ground is.

Diane Jeffery

I think the current bill going through houses of commons recommending a statutory inspectorate "offcos" is probably more of an indicator of how things will pan out.

Diane Jeffery

Re I welcome the report as a whole - the industry really needs to be more regulated. Re Point two fo the recommendations "Non-healthcare practitioners who have achieved the required accredited qualification may perform these procedures under the supervision of an appropriate qualified clinical professional." This however does not go far enough. Non Healthcare proffesionals should not be allowed to administer non surgical procedures - as they will not be able to cope if the procedure go wrong!...the words"under the supervision" will be interpreted by people in different ways - for example under the supervision does not necessarily mean the Prescribing Dr needs to be present during the procedure..hence the patient/client is still left exposed if the procedure goes wrong.

Libby

I agree Libby and I can't see the point in making fillers prescription only and then allowing non medical staff carry out procedures. Botox is prescription only and beauty therapists etc manage to obtain it, albeit with the help of a prescriber somewhere, making fillers prescription only won't stop them. If only nurses, doctors and dentists were allowed to administer and we all adhered to our own codes of conduct etc with nmc/gmc/gdc it could be argued we wouldn't need much more regulation, we all have our own regulatory bodies already.

Diane Jeffery

Interesting debate! Of course everyone running a reputable clinic will support Keogh as they already support regulation. The problem will always lie with the clinics and practitioners who have no business being in business. Self-regulation simply doesn't work for the simple reason that the good guys are already good and the bad guys will always be bad! The BACN comments are spot on and the questions they raise are brave and not sycophantic. Until these questions are answered Keogh will remain a report we look back upon in another 5 years, self-regulation will be an expensive cost centre for good clinics thereby driving paying customers into the hands of the (cheaper) bad clinics who will continue to flout every regulation. The CQC aren't really interested, didn't they try to regulate nurse injectors several years ago but fail? Wasn't it the CQC who de-regulated lasers which, strangely, left Laser clinics suddenly liable for VAT. I am not hopeful!!!!
Robert Houtman. Managing Director National Slimming and Cosmetic Clinics.

Robert Houtman